Abstract
Avian metapneumovirus (aMPV), also known as avian pneumovirus or turkey rhinotracheitis virus, is the causative agent of turkey rhinotracheitis and is associated with swollen head syndrome in chickens. aMPV belongs to the family Paramyxoviridae which includes many important human pathogens such as human respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and human parainfluenza virus type 3 (PIV3). The family also includes highly lethal emerging pathogens such as Nipah virus and Hendra virus, as well as agriculturally important viruses such as Newcastle disease virus (NDV). For many of these viruses, there is no effective vaccine. Here, we describe a reverse genetics approach to develop live attenuated aMPV vaccines by inhibiting the viral mRNA cap methyltransferase. The viral mRNA cap methyltransferase is an excellent target for the attenuation of paramyxoviruses because it plays essential roles in mRNA stability, efficient viral protein translation and innate immunity. We have described in detail the materials and methods used to generate recombinant aMPVs that lack viral mRNA cap methyltransferase activity. We have also provided methods to evaluate the genetic stability, pathogenesis, and immunogenicity of live aMPV vaccine candidates in turkeys.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Broor S, Bharaj P (2007) Avian and human metapneumovirus. Ann N Y Acad Sci 1102:66–85
Easton AJ, Domachowske JB, Rosenberg HF (2004) Animal pneumoviruses: molecular genetics and pathogenesis. Clin Microbiol Rev 17:390–412
Hafez HM, Hess M, Prusas C, Naylor CJ, Cavanagh D (2000) Presence of avian pneumovirus type A in continental Europe during the 1980s. J Vet Med B Infect Dis Vet Public Health 47:629–633
Aung YH, Liman M, Neumann U, Rautenschlein S (2008) Reproducibility of swollen sinuses in broilers by experimental infection with avian metapneumovirus subtypes A and B of turkey origin and their comparative pathogenesis. Avian Pathol 37:65–74
Toquin D, Guionie O, Jestin V, Zwingelstein F, Allee C, Eterradossi N (2006) European and American subgroup C isolates of avian metapneumovirus belong to different genetic lineages. Virus Genes 32:97–103
Wei L, Zhu S, Yan X, Wang J, Zhang C, Liu S, She R, Hu F, Quan R, Liu J (2013) Avian metapneumovirus subgroup C infection in chickens, China. Emerg Infect Dis 19:1092–1094
Govindarajan D, Buchholz UJ, Samal SK (2006) Recovery of avian metapneumovirus subgroup C from cDNA: cross-recognition of avian and human metapneumovirus support proteins. J Virol 80:5790–5797
Turpin EA, Stallknecht DE, Slemons RD, Zsak L, Swayne DE (2008) Evidence of avian metapneumovirus subtype C infection of wild birds in Georgia, South Carolina, Arkansas and Ohio, USA. Avian Pathol 37:343–351
Goyal SM, Chiang SJ, Dar AM, Nagaraja KV, Shaw DP, Halvorson DA, Kapur V (2000) Isolation of avian pneumovirus from an outbreak of respiratory illness in Minnesota turkeys. J Vet Diagn Invest 12:166–168
Alkhalaf AN, Ward LA, Dearth RN, Saif YM (2002) Pathogenicity, transmissibility, and tissue distribution of avian pneumovirus in turkey poults. Avian Dis 46:650–659
Padhi A, Poss M (2009) Population dynamics and rates of molecular evolution of a recently emerged paramyxovirus, avian metapneumovirus subtype C. J Virol 83:2015–2019
Wei Y, Feng K, Yao X, Cai H, Li J, Mirza AM, Iorio RM (2012) Localization of a region in the fusion protein of avian metapneumovirus that modulates cell-cell fusion. J Virol 86:11800–11814
van den Hoogen BG, de Jong JC, Groen J, Kuiken T et al (2001) A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7:719–724
van den Hoogen BG, Herfst S, Sprong L, Cane PA et al (2004) Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10:658–666
Wei Y, Zhang Y, Cai H, Mirza AM, Iorio RM, Peeples ME, Niewiesk S, Li J (2014) Roles of the putative integrin-binding motif of the human metapneumovirus fusion (f) protein in cell-cell fusion, viral infectivity, and pathogenesis. J Virol 88:4338–4352
Velayudhan BT, Nagaraja KV, Thachil AJ, Shaw DP, Gray GC, Halvorson DA (2006) Human metapneumovirus in turkey poults. Emerg Infect Dis 12:1853–1859
Ganapathy K, Jones RC (2007) Vaccination of chicks with live attenuated subtype B avian metapneumovirus vaccines: protection against challenge and immune responses can be unrelated to vaccine dose. Avian Dis 51:733–737
Naylor CJ, Ling R, Edworthy N, Savage CE, Easton AJ (2007) Avian metapneumovirus SH gene end and G protein mutations influence the level of protection of live-vaccine candidates. J Gen Virol 88(Pt 6):1767–1775
Patnayak DP, Gulati BR, Sheikh AM, Goyal SM (2003) Cold adapted avian pneumovirus for use as live, attenuated vaccine in turkeys. Vaccine 21:1371–1374
Patnayak DP, Sheikh AM, Gulati BR, Goyal SM (2002) Experimental and field evaluation of a live vaccine against avian pneumovirus. Avian Pathol 31:377–382
Hu H, Roth JP, Estevez CN, Zsak L, Liu B, Yu Q (2011) Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys. Vaccine 29:8624–8633
Lupini C, Cecchinato M, Ricchizzi E, Naylor CJ, Catelli E (2011) A turkey rhinotracheitis outbreak caused by the environmental spread of a vaccine-derived avian metapneumovirus. Avian Pathol 40:525–530
Velayudhan BT, Noll SL, Thachil AJ, Shaw DP et al (2007) Development of a vaccine-challenge model for avian metapneumovirus subtype C in turkeys. Vaccine 25:1841–1847
Whelan SP, Barr JN, Wertz GW (2004) Transcription and replication of nonsegmented negative-strand RNA viruses. Curr Top Microbiol Immunol 283:61–119
Sun J, Wei Y, Rauf A, Zhang Y et al (2014) Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain. J Virol 88:12348–12363
Zhang Y, Wei Y, Zhang X, Cai H, Niewiesk S, Li J (2014) Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase. J Virol 88:11411–11429
Li J, Fontaine-Rodriguez EC, Whelan SP (2005) Amino acid residues within conserved domain VI of the vesicular stomatitis virus large polymerase protein essential for mRNA cap methyltransferase activity. J Virol 79:13373–13384
Li J, Rahmeh A, Morelli M, Whelan SP (2008) A conserved motif in region v of the large polymerase proteins of nonsegmented negative-sense RNA viruses that is essential for mRNA capping. J Virol 82:775–784
Li J, Wang JT, Whelan SP (2006) A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc Natl Acad Sci U S A 103:8493–8498
Ma Y, Wei Y, Zhang X, Zhang Y et al (2014) mRNA cap methylation influences pathogenesis of vesicular stomatitis virus in vivo. J Virol 88:2913–2926
Acknowledgements
This study was supported by grants from the USDA NIFA Animal Health Program (2010-65119-20602) and the NIH (R01AI090060).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Zhang, Y., Sun, J., Wei, Y., Li, J. (2016). A Reverse Genetics Approach for the Design of Methyltransferase-Defective Live Attenuated Avian Metapneumovirus Vaccines. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 1404. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-3389-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3389-1_7
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-3388-4
Online ISBN: 978-1-4939-3389-1
eBook Packages: Springer Protocols